| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Corp. &Comm. Officer | Chief Commercial Officer | Chief Commercial Officer
1 company
Moat Ross is a Chief Corp. &Comm. Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $536K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Corp. &Comm. Officer | Sell | 3,523 | $35.31 | $124,397.13 | -27.2% | +14.3% | - | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Commercial Officer | Sale+OE | 27,594 | $29.02 | $800,777.88 | -74.6% | +17.8% | - | |
| May 5, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Commercial Officer | Sale+OE | 10,122 | $28.00 | $283,416.00 | -35.0% | +18.6% | +99.0% | |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Commercial Officer | Sale+OE | 87,269 | $25.96 | $2,265,339.03 | -82.3% | +8.4% | +99.2% | |
| Apr 21, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Commercial Officer | Sell | 18,259 | $20.29 | $370,475.11 | -66.0% | +41.7% | - | |
| Sep 3, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Commercial Officer | Sale+OE | 68,506 | $26.12 | $1,789,189.80 | -60.6% | -16.0% | +36.4% |